Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1009-e1011. doi: 10.1111/jdv.18406. Epub 2022 Jul 13.

Authors

K Oya¹, Y Nakamura¹, K Iwamoto¹, T Kimura², H Negoro², H Nishiyama², Y Fujisawa¹

Affiliations

¹ Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
² Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

PMID: 35789043
DOI: 10.1111/jdv.18406

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal* / adverse effects
Apoptosis
Humans
Keratinocytes
Miliaria*

Substances

enfortumab vedotin
Antibodies, Monoclonal